Paxlovid didn’t short­en Covid symp­toms in vac­ci­nat­ed adults, full tri­al re­sults con­firm

“If it’s Covid, Paxlovid.”

That’s how Pfiz­er mar­kets its Covid-19 an­tivi­ral, even as the full re­sults of a study pub­lished in the New Eng­land Jour­nal …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.